Prostate Adenocarcinoma Clinical Trials in Portland, Oregon

7 studies are recruiting for prostate adenocarcinoma in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

   This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a p…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Providence Portland Medical Center, Portland, Oregon

   Locations

   413 in total

   Run by

   NRG Oncology

   See if you can join NCT05946213 on ClinicalTrials.gov

2. MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

   Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (different techniques for taking images that allow doctors to visualize the body's internal structures) of the prostate. Participation in this r…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Oregon Health & Science University, Portland, Oregon

   Locations

   2 in total

   Run by

   University of Chicago

   See if you can join NCT05710380 on ClinicalTrials.gov

3. A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

   Researchers conducting this study hope to learn about the safety and effectiveness of combining two study drugs, relacorilant and enzalutamide, plus androgen deprivation therapy (ADT), also known as hormone therapy. This study is for individuals who have been diagnosed with advanced, high-risk pros…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Oregon Health & Science University, Portland, Oregon

   Locations

   4 in total

   Run by

   University of Chicago

   See if you can join NCT05726292 on ClinicalTrials.gov

4. Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

   This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective c…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Providence Portland Medical Center, Portland, Oregon

   Locations

   341 in total

   Run by

   ECOG-ACRIN Cancer Research Group

   See if you can join NCT04423211 on ClinicalTrials.gov

5. Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

   The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy.

   Stage

   Phase 1

   Ages

   21 and older

   Site

   VA Portland Health Care System, Portland, Oregon

   Locations

   10 in total

   Run by

   Alessa Therapeutics Inc.

   See if you can join NCT06257693 on ClinicalTrials.gov

6. Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

   This phase II trial tests how well carboplatin before surgery works in treating patients with high-risk prostate cancer and an inherited BRCA1 or BRCA2 gene mutation. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug ci…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Providence Portland Medical Center, Portland, Oregon

   Locations

   133 in total

   Run by

   SWOG Cancer Research Network

   See if you can join NCT05806515 on ClinicalTrials.gov

7. Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

   This clinical trial investigates the change in prostate-specific membrane antigen (PSMA) expression in response to hormonal therapy in both, Castration Sensitive Prostate Cancer (CSPC) and Castration Resistant Prostate Cancer (CRPC), and whether this change in PSMA expression changes tumor staging …

   Stage

   Phase 4

   Ages

   18 and older

   Site

   OHSU Knight Cancer Institute, Portland, Oregon

   Run by

   OHSU Knight Cancer Institute

   See if you can join NCT05919329 on ClinicalTrials.gov